Karen Flynn Net Worth & Insider Trades

Karen Flynn - Director, Recro Pharma, Inc

As of December 16, 2019

What is Karen Flynn's Net Worth?

The current estimated net worth of Recro Pharma, Inc's Director, Karen Flynn, is estimated to be about $14.1M . Karen Flynn owns about 800 units of Recro Pharma, Inc common stock. In the last 4 years at Recro Pharma, Inc, Karen Flynn has sold an estimated value of $0 worth.

What is Karen Flynn's Past Insider Trading?

Karen Flynn's largest purchase order was 800 units , worth over $5.36K on December 19, 2016. In total, Karen Flynn has made about 8 transactions over 4 years of their time at Recro Pharma, Inc. Karen Flynn usually trades in May, with the busiest year in 2019, 2015 and 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Karen Flynn's' Mailing Address?

  • Mailing address is C/o Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 NJ

Recro Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
J. David Enloe, Jr. 2020 $10,577 - $660,001 $400,544 - $1,678 $1,072,800
Ryan D. Lake 2020 $198,985 $48,000 $1,058,040 $744,327 $107,640 $24,673 $2,181,665
Ryan D. Lake 2019 $319,777 $69,440 $623,276 $334,200 $138,880 $44,038 $1,529,611
Gerri Henwood 2020 $308,654 $111,240 - - - $21,166 $441,060
Gerri Henwood 2019 $553,846 - $2,608,537 $1,062,199 $360,000 $38,402 $4,622,984
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm

What are Recro Pharma, Inc's Past Insider Trades?

Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer,  Geraldine Henwood, Director,  and Scp Vitalife Partners Ii Lp .

Recro Pharma, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1